Abstract:The translocation t(8;21) (q22;q22) frequently associated with additional chromosomal aberrations is one of the most recurrent chromosomal abnormalities in AML. Clinically, this type of AML usually shows some specific characteristics and has a good response to chemotherapy with a high remission rate and a relatively long median survival.On the other hand, some reports also showed poor prognosis in AML patients with t(8;21 ) , and the associated bad prognosis factors have not been strongly established to date. To investigate this issue and to further identify the related characteristics of t(8 ;21 ) AML in China, 75 Chinese AML patients with t(8 ;21 ) were retrospectively analyzed. They comprised 68 cases of M2, five of M4 and two of M5 according to FAB classification. The results indicated that Auer rods were observed in 39 patients (52%) and marrow eosinophilia was detected in only 5 patients (6.7%). These patients showed high level of HLA-DR and CD34 expression, while CD19 was detected in only 13 patients (20.9%). Cytogenetically, 62.5 % cases had additional chromosomal abnormalities, and the main associated recurrent additional abnormalities were loss of a sex chromosome (LOS), trisomy 4, del (9q) and trisomy 8. After conventional induction therapy, 62 patients attained complete remission (CR) resulting in the CR rate 82.7%. With a follow-up of 1 to 96 months, 19 cases relapsed at a median time of 10.5 months (range 3 to 42 months). The median overall survival was 20 months, and the estimated 5-year overall survival (OS) rate was 32.3%. In multivariate analyses of prognostic factors,karyotype, extramedullary leukemia, age and post-remission therapy were of prognostic value for OS. Patients with additional chromosomal anomalies had shorter survival compared to those with t(8 ;21 ) only (P = 0.019), no matter which kind of additional karyotype it was. Extramedullary leukemia was an adverse prognostic factor ( P = 0. 012). Patients aged 15 years or less had a longer survival than those aged more than 15 years (P =0.045). Patients accepted HSCT in post-remission therapy had better outcome compared to those with chemotherapy only. It is concluded that Chinese AML patients with t(8 ;21 ) had some different characteristics as compared with patients from other countries, a relatively poor outcome was observed in our patients, especially in those with extramedullary leukemia or additional chromosomal abnormalities. HSCT should be recommended to t(8 ;21 ) AML in China, especially to those with adverse prognostic factors.

[Characteristics of Cases with Chromosome 3q21q26 Aberrations].

Clinical Analysis of 24 Cases of Acute Myeloid Leukemia with 3q Abnormalities

Unusual Findings Of Acute Myeloid Leukemia With Inv(3)(Q21q26.2) Or T(3;3)(Q21;Q26.2): A Multicenter Study

[Clinical and Laboratory Investigation of Hematological Malignancy Patients Carrying 3q21q26 Rearrangement].

[Cytogenetic and Clinical Analysis of -7/7Q- Abnormalities in Acute Leukemia and Myelodysplastic Syndrome].

Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia

[Analysis of 32 Cases of Acute Leukemia with Abnormality of Chromosome 7].

[Clinical Analysis of Myeloid Neoplasms with T (3;21) (Q26;q22)].

Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 1

[Clinical and Cytogenetics Studies on Acute Myeloid Leukemia with Abnormality of Chromosome 11].

t(X;17) as the sole karyotypic anomaly in a case of M(3r) subtype of acute promyelocytic leukemia without RARalpha rearrangement.

Conventional cytogenetics and breakpoint distribution by fluorescent in situ hybridization in patients with malignant hemopathies associated with inv(3)(q21;q26) and t(3;3)(q21;q26)

The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2)

Clinical analysis on 15 acute myeloid leukemia patients with 11p15 abnormalities

[Cytogenetic Analysis of 154 Case of Acute Myeloid Leukemia with T(8;21)].

[Clinical and Cytogenetic Features of Hematologic Malignancies Associated with Acquired Trisomy 21].

Clinical and Experimental Study of Two Cases of Myelodysplastic Syndrome with T(3; 5) (q25; Q34) Translocation.

3Q26.2/mecom Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features

[Analysis of Characteristics of 72 Cases of T(8;21) Acute Myeloid Leukemia].

Characteristics and Prognostic Factors of Acute Myeloid Leukemia with T( 8 ;21 ) ( Q22; Q22)

A new case of myelodysplastic syndrome associated with t(3;3)(q21;q26) and inv(11)(p15q22)